Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (225)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
140
Price
$492.72
Total Value
$68.98K
Shares Held After
333,343
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$491.04
Total Value
$108.03K
Shares Held After
333,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$483.90
Total Value
$96.78K
Shares Held After
333,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$481.91
Total Value
$19.28K
Shares Held After
333,903
% of Holdings
0.0%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
8,530
Price
$18.97
Total Value
$161.81K
Shares Held After
399,130
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,069
Price
$46.01
Total Value
$49.19K
Shares Held After
458,977
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
7,141
Price
$45.55
Total Value
$325.31K
Shares Held After
460,046
% of Holdings
1.5%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
23,429
Price
$10.92
Total Value
$255.75K
Shares Held After
1,449,765
% of Holdings
1.6%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
871
Price
$42.92
Total Value
$37.38K
Shares Held After
59,882
% of Holdings
1.4%
UroGen Pharma Ltd. (URGN)
Smith Jason Drew — General Counsel
Shares
1,519
Price
$42.54
Total Value
$64.62K
Shares Held After
53,141
% of Holdings
2.8%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
15,000
Price
$40.68
Total Value
$610.13K
Shares Held After
65,179
% of Holdings
18.7%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
5,294
Price
$6.02
Total Value
$31.86K
Shares Held After
625,350
% of Holdings
0.8%
AN2 Therapeutics, Inc. (ANTX)
Readnour Robin Shane — Director
Shares
4,725
Price
$6.02
Total Value
$28.44K
Shares Held After
557,990
% of Holdings
0.8%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.46
Total Value
$41.14K
Shares Held After
17,217
% of Holdings
12.7%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$113.52
Total Value
$567.58K
Shares Held After
424,360
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
185
Price
$18.88
Total Value
$3.49K
Shares Held After
152,897
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,290
Price
$18.88
Total Value
$24.36K
Shares Held After
162,564
% of Holdings
0.8%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
5,658
Price
$18.88
Total Value
$106.82K
Shares Held After
357,507
% of Holdings
1.6%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$75.46
Total Value
$264.11K
Shares Held After
153,902
% of Holdings
2.2%
Inhibrx Biosciences, Inc. (INBX)
FORSYTH DOUGLAS — Director
Shares
2,500
Price
$114.65
Total Value
$286.62K
Shares Held After
227,064
% of Holdings
1.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
9,681
Price
$112.28
Total Value
$1.09M
Shares Held After
730,548
% of Holdings
1.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,219
Price
$111.88
Total Value
$136.38K
Shares Held After
720,867
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
500
Price
$108.23
Total Value
$54.12K
Shares Held After
719,648
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
1,100
Price
$107.12
Total Value
$117.84K
Shares Held After
719,148
% of Holdings
0.2%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
6,605
Price
$100.64
Total Value
$664.72K
Shares Held After
718,048
% of Holdings
0.9%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
5,895
Price
$99.29
Total Value
$585.34K
Shares Held After
711,443
% of Holdings
0.8%
CYBIN INC. (CYBN)
So Eric H. L. — Director
Shares
100,000
Price
$12.09
Total Value
$1.21M
Shares Held After
4,365,014
% of Holdings
2.3%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
2,073,558
% of Holdings
10.6%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
220,070
Price
$11.17
Total Value
$2.46M
Shares Held After
4,711,801
% of Holdings
4.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,111
Price
$193.13
Total Value
$1.57M
Shares Held After
96,134
% of Holdings
7.8%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,209
Price
$192.54
Total Value
$810.41K
Shares Held After
104,245
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
11,080
Price
$191.15
Total Value
$2.12M
Shares Held After
108,454
% of Holdings
9.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
600
Price
$190.39
Total Value
$114.23K
Shares Held After
119,534
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,955
Price
$189.34
Total Value
$1.70M
Shares Held After
120,134
% of Holdings
6.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,045
Price
$188.26
Total Value
$573.25K
Shares Held After
129,089
% of Holdings
2.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,200
Price
$187.25
Total Value
$1.16M
Shares Held After
132,134
% of Holdings
4.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
7,800
Price
$186.32
Total Value
$1.45M
Shares Held After
138,334
% of Holdings
5.3%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,593
Price
$185.34
Total Value
$851.29K
Shares Held After
146,134
% of Holdings
3.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,252
Price
$184.52
Total Value
$1.15M
Shares Held After
150,727
% of Holdings
4.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
4,955
Price
$183.30
Total Value
$908.23K
Shares Held After
156,979
% of Holdings
3.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,413
Price
$182.50
Total Value
$622.87K
Shares Held After
161,934
% of Holdings
2.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,587
Price
$181.24
Total Value
$468.88K
Shares Held After
165,347
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,635
Price
$180.29
Total Value
$475.07K
Shares Held After
167,934
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,602
Price
$193.12
Total Value
$888.73K
Shares Held After
44,000
% of Holdings
9.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,398
Price
$192.40
Total Value
$653.79K
Shares Held After
48,602
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
6,200
Price
$191.09
Total Value
$1.18M
Shares Held After
52,000
% of Holdings
10.7%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,800
Price
$190.63
Total Value
$343.14K
Shares Held After
58,200
% of Holdings
3.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
6,200
Price
$189.22
Total Value
$1.17M
Shares Held After
60,000
% of Holdings
9.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,900
Price
$188.59
Total Value
$358.32K
Shares Held After
66,200
% of Holdings
2.8%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
3,900
Price
$187.16
Total Value
$729.94K
Shares Held After
68,100
% of Holdings
5.4%
Showing 101–150 of 225 transactions (page 3 of 5)